Ads
related to: narcolepsy- Living With Narcolepsy
Learn How to Manage Living With
Your EDS and/or Cataplexy Today.
- Patient Brochure
Learn Important Information
About the Treatment.
- Potential Health Risks
Learn About the Potential Risks
of EDS and/or Cataplexy Treatment.
- Discover Patient Stories
Learn More About The Daily Life of
Patients Living With Narcolepsy.
- Treatment Savings Program
Learn How to Save on Your
EDS in Narcolepsy Medication.
- Sign Up for More Info
Receive Important Updates
About EDS/Cataplexy Treatment.
- Living With Narcolepsy
Search results
Axsome's (AXSM) Narcolepsy Drug Study Meets Primary Goal
Zacks via Yahoo Finance· 3 days agoData from a late-stage study shows that a five-week treatment with Axsome's (AXSM) experimental ...
Narcolepsy patients report high symptom persistence
Investing.com· 4 days agoNarcolepsy patients report high symptom persistence
Axsome drug succeeds in narcolepsy symptoms trial
BioPharma Dive via Yahoo Finance· 4 days agoDespite the late-stage victory, shares of the New York-based biotech dipped more than 3%. One analyst argued that Axsome’s drug has “largely been falling...
3 Strong Buy Biotech Stocks to Add to Your Q2 Must-Watch List
InvestorPlace· 2 days agoGiven the timeline of clinical trials and new releases, these biotech stocks can be some of the best...
AXS-12 shows promise in narcolepsy treatment, trial finds By Investing.com
Investing.com· 4 days agoAxsome Therapeutics, Inc. (NASDAQ: NASDAQ:AXSM), a biopharmaceutical company, announced today...
Axsome's sleep disorder drug succeeds in late-stage trial, shares rise
Reuters· 4 days ago, opens new tab said on Monday its experimental therapy cut the frequency of disruptive episodes of muscle weakness tied to a sleep disorder called narcolepsy in a late-stage ...
Depression TMS Cleared for Teens; Phase III Narcolepsy Win; Fake ADHD Diagnosis?
MedPage Today· 2 days agoAn analysis of Facebook posts using artificial intelligence models was able to predict depression severity for white individuals, but not Black individuals. Reboxetine -- a norepinephrine reuptake ...
Zevra Therapeutics Inc (ZVRA) Earnings: A Mixed Bag Against Analyst Estimates with Significant ...
GuruFocus.com via Yahoo Finance· 17 hours agoThe company's approach combines science, data, and patient needs. Its lead products include...
Pain medication recall as dire warning issued
Newsweek· 5 hours agoA pain-relieving injection has been recalled after a customer found white particles floating inside the vial. The pharmaceutical company Eugia US LLC has...
Centessa Pharmaceuticals PLC (CNTA) Earnings: A Detailed Look at Q4 and Full-Year 2023 Results
GuruFocus.com via Yahoo Finance· 17 hours agoCentessa Pharmaceuticals PLC (NASDAQ:CNTA) focuses on developing transformational medicines for patients with its advanced programs targeting hemophilia, narcolepsy, and cancer ...
Ads
related to: narcolepsy